Skip to main content
. Author manuscript; available in PMC: 2018 Jul 25.
Published in final edited form as: Stroke. 2016 Apr 12;47(5):1389–1398. doi: 10.1161/STROKEAHA.115.012364

Table 3.

Imaging selection criteria for recent positive acute stroke clinical trials

Imaging
selection
criteria
MR
CLEAN
EXTEND
-IA
ESCAPE SWIFT
PRIME
REVASCAT THERAPY
Vessel occlusion ICA, M1, M2, A1, A2 occlusion ICA,
M1,
M2
ICA, M1 or functional M1 occlusion (both/all M2 occlusion) ICA, M1 ICA or M1 occlusion ICA, M1 or M2 occlusion
-Hyperdense clot length ≥8 mm
-Absence of tandem extracranial steno-occlusive disease
requiring treatment prior to thrombectomy
Small core Not required RAPID perfusion infarct <70mL (relCBF<30%
threshold)
ASPECTS
score
6–10
ASPECTS
score
6–10 on NCT or DWI,
RAPID perfusion infarct <50mL (relCBF<30%
threshold)
ASPECTS
score
>6 on NCCT,
ASPECTS
score
>5 on DWI (NCCT ASPECTS >8 for age 80–85)
Acute ischemic changes on NCCT less than one-third of MCA territory
Penumbra Not required Target mismatch:
RAPID perfusion ischemic core mismatch ratio>1.2,
absolute mismatch
>10mL
(Tmax>6 sec threshold)
Not required Target
Mismatch:
RAPID perfusion penumbra/infarct ratio>1.8,
penumbra absolute volume
>15mL
(Tmax>6 sec threshold)
- Tmax>10s
lesion
≤100mL
Not required (Clinical/core mismatch [NIHSS >5]) Not required
Collaterals Not required Not required Adequate
collateral
circulation
defined
as
some
filling
of
50%
or
greater
of
the
ischemic
territory
pial
circulation
beyond
occlusion
on
CT
angiography
(preferably
multiphase
CTA)
Not required Not required Not required